Live feed
Filing
SC 13G
SC 13G0001839882-24-044356·Affinity Asset Advisors, LLC
Schedule 13G ownership disclosure
INOZYME PHARMA INC
Security class unavailable · CUSIP: 45790W108
Event date: 2024-12-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,972,318
- Percent of class
- 6.1800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001839882-24-044356
- Form type
- SC 13G
- Filer
- Affinity Asset Advisors, LLC
- CIK
- CIK 1773195
- Filed
- Dec 09, 2024
- Reporting period
- Dec 02, 2024
- Description
- Schedule 13G beneficial ownership